Results 161 to 170 of about 920,092 (279)

GLP-2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. [PDF]

Physiol Rep
Galsgaard KD, Hartmann B, Rosenkilde MM, Holst JJ, Gasbjerg LS, Sørensen CM.   +5 more
europepmc   +1 more source

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge. [PDF]

Cureus, 2022
Lopes S, Alves M, Rodrigues P.
europepmc   +1 more source

Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low-Voltage Areas in Patients With Atrial Fibrillation. [PDF]

J Am Heart Assoc
Nishino K, Temma T, Natsui H, Watanabe M, Nakao M, Kawasaki M, Shimano K, Kawakami K, Saito S, Koya J, Tatsuta D, Koizumi T, Kadosaka T, Koya T, Tsuneta S, Kamiya K, Nagai T, Anzai T.   +17 more
europepmc   +1 more source

Amygdalin regulated vasoactive intestinal peptide receptor to protect alveolar epithelial barrier against lung injury induced by influenza a virus. [PDF]

Chin Med
Song X, Wang T, Ye M, Shi X, Chen D, Lu Y, Zhu H.   +6 more
europepmc   +1 more source

Allele-specific cis-regulatory methylation of the gene for vasoactive intestinal peptide in white-throated sparrows. [PDF]

Genes Brain Behav, 2022
Prichard MR, Grogan KE, Merritt JR, Root J, Maney DL.   +4 more
europepmc   +1 more source

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10. [PDF]

Int J Mol Sci
Gutzler C, Höhne K, Bani D, Kayser G, Fähndrich S, Ambros M, Hug MJ, Rieg S, Falcone V, Müller-Quernheim J, Zissel G, Frye BC.   +11 more
europepmc   +1 more source

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature. [PDF]

AACE Clin Case Rep, 2022
Yee SK, Meyer JH, Wong LL.
europepmc   +1 more source

Clinical implications of vasoactive intestinal peptide and 5-hydroxytryptamine in diabetic neurogenic bladder and their relationship with post-void residual. [PDF]

J Med Biochem
Shi L, Zhang S, Cai L, Zhang J, Liu G, Wang X, Ji F, Sun Y, Wei Z.   +8 more
europepmc   +1 more source

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes. [PDF]

Front Endocrinol (Lausanne), 2022
Hou X, Yang D, Yang G, Li M, Zhang J, Zhang J, Zhang Y, Liu Y.   +7 more
europepmc   +1 more source

Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.

Journal of Clinical Investigation, 1974
Charles J. Schwartz, D. V. Kimberg, H. Sheerin, Michael Field, Sami I. Said   +4 more
semanticscholar   +1 more source